Early screening of myocardial injury and lethal arrhythmia by 64-channel magnetocardiography and genetical predisposition

64道心磁图及遗传易感性早期筛查心肌损伤和致死性心律失常

基本信息

  • 批准号:
    18500383
  • 负责人:
  • 金额:
    $ 2.59万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

The aim of this study is to develop an early screening of myocardial damage and lethal arrhythmia by 64 channel Magnetocardiography (64-chMCG) and to analyze its genetical predisposition for avoiding side effect by chemotherapy.Results :1. We developed a three-dimensional RTc dispersion map for detecting early myocardial injury and three-dimensional spectral map by 64-ch MCG (Nakai, et. al. Int J Card Imaging, 2006)).2. We developed a three-dimensional spectral map of atrial fibrillation who received adjunctive pulmonary isolation followed by valve replacement. The mean frequency by three-dimensional spectral map by 64-ch MCG could demonstrate a pre-operative value for PV isolation (Nakai, et. al. ; J Electrocardiol, 2008)3. We analyzed the C677T polymorphism of 5, 10'-methylenetrtrahydroforate reductase (5, 10'-MTHFR) in 15 patients with bladder tumor who received a combined MVAC chemotherapy. Obara, et al. reported that C677T polymorphism related the effect and acquired capacity of Methotrexate by a MVAC therapy (Obara, et al. 2007).4. We reported the significance of ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in patients with cardiovascular surgery. (Pharmacogenomics, 2007).5. We developed the 187-ch signal-averaged vector-projected ECG (SAVP) depend on the algorithm of 64-ch MCG for detecting lethal arrhythmia and injured myocardial repolarization (Nakai, et al. Int Heart J, 2007).In conclusion, we developed a 64-ch MCG and 187-ch SAVP ECG and verified the clinical significance for detecting myocardial injury and lethal arrhythmia. We also demonstrated the utility of SNPs as an individualized therapy for predisposition for drug metabolism.
本研究的目的是建立64通道心脏磁图(64- chmcg)早期筛查心肌损害和致死性心律失常,并分析其遗传易感性,以避免化疗的副作用。结果:1。我们开发了用于检测早期心肌损伤的三维RTc弥散图和64-ch MCG的三维光谱图(Nakai等,Int J Card Imaging, 2006)。我们开发了心房颤动的三维频谱图谁接受辅助肺隔离后瓣膜置换术。64-ch MCG三维频谱图的平均频率可以显示PV隔离的术前价值(Nakai等人;J Electrocardiol, 2008)3。我们分析了15例接受MVAC联合化疗的膀胱肿瘤患者的5,10 '-亚甲基四氢甲酸还原酶(5,10 '-MTHFR)的C677T多态性。Obara等人报道C677T多态性与MVAC治疗甲氨蝶呤的效果和获得能力有关(Obara等人,2007)。我们报道了心血管手术患者中VKORC1基因多态性的种族差异的意义以及与华法林剂量需求的关联。(药物基因组学,2007)。5。我们基于64-ch MCG算法开发了187-ch信号平均矢量投影ECG (SAVP),用于检测致死性心律失常和损伤心肌复极(Nakai等)。国际心脏杂志,2007)。总之,我们研制了64-ch MCG和187-ch SAVP心电图,验证了检测心肌损伤和致死性心律失常的临床意义。我们还证明了snp作为药物代谢易感性的个体化治疗的效用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Screening the Single Nucleotide Polymorphisms in Patients with Internal Carotid Artery Stenosis by Oligonucleotide-Based Custom DNA Array.
通过基于寡核苷酸的定制 DNA 阵列筛选颈内动脉狭窄患者的单核苷酸多态性。
Screening the Single Nucleotide Polymorphisms in Patients with Internal Carotid Artery Stenosis by Oligonucleotide-Based Custom DNA Array
基于寡核苷酸的定制DNA芯片筛查颈内动脉狭窄患者的单核苷酸多态性
Development of a Signal-Averaged Vector-Projected 187-Channel High-Resolutio Electrocardiogram for the Evaluation of the Spatial Location of High-Frequency Potentials and Abnormal Ventricular Repolarization
开发信号平均矢量投影 187 通道高分辨率心电图,用于评估高频电位和异常心室复极的空间位置
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakai K;Tsuboi J;Okabayashi H;et. al.
  • 通讯作者:
    et. al.
Ethnic Differences in the VKORC1 Gene Polymorphism and an Association With Warfarin Dosage Requirements in Patients With Cardiovascular Surgery.
VKORC1 基因多态性的种族差异及其与心血管手术患者华法林剂量需求的关系。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakai. K;Tsuboi. J;Okabayashi. H;et. al.
  • 通讯作者:
    et. al.
Ethnic differences in the VKORCl gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients.
VKORC1基因多态性的种族差异及其与心血管手术患者华法林剂量需求的关联。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kenji Nakai;et. al.
  • 通讯作者:
    et. al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAI Kenji其他文献

NAKAI Kenji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAI Kenji', 18)}}的其他基金

Development of software system for next-generation multi-channel high amplification and high resolution ECG and clinical application
新一代多通道高放大高分辨率心电图软件​​系统开发及临床应用
  • 批准号:
    22590792
  • 财政年份:
    2010
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Determination of Impact Indentation Hardness for Metallic Materials and Impact Fracture Toughness for Brittle Materials
金属材料冲击压痕硬度和脆性材料冲击断裂韧性的测定
  • 批准号:
    21760563
  • 财政年份:
    2009
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
A development of oligonucleotide based DNA array for CYP2C9 genotyping for individual therapy in patients with valve replacement receiving warfarin therapy
开发基于寡核苷酸的 DNA 阵列,用于 CYP2C9 基因分型,用于接受华法林治疗的瓣膜置换术患者的个体化治疗
  • 批准号:
    15590768
  • 财政年份:
    2003
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of genetical factor in the Japanese is chemic heart disease
日本人化学性心脏病遗传因素评价
  • 批准号:
    09670743
  • 财政年份:
    1997
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The significance of ACE gene polymorphism in ischemic heart disease
ACE基因多态性在缺血性心脏病中的意义
  • 批准号:
    07670801
  • 财政年份:
    1995
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Noble method for evaluation of the drug induced QT prolongation in patients with atrial fibrillation and associated gene abnormality
评估心房颤动及相关基因异常患者药物引起的 QT 延长的 Noble 方法
  • 批准号:
    24591040
  • 财政年份:
    2012
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism and clinical trial center for the drug-induced QT prolongation syndrome
药物引起的QT间期延长综合征的分子机制及临床试验中心
  • 批准号:
    16390222
  • 财政年份:
    2004
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了